INTRODUCTION ABSTRACT
The product quality of materials including explosives, catalysts, pigments, and pharmaceuticals can be significantly influenced by their physical properties such as particle size distribution and morphology. 1, 2 Fine particles of pharmaceuticals with a narrow particle size distribution are essential for the development of inhalation aerosols, injectable suspensions, controlled release dosage forms, and other specialized drug delivery systems. In addition, particle size is a critical parameter that determines the rate of dissolution of the drug in the biological fluids and, hence, has a significant effect on the bioavailability of the poorly water-soluble drugs for which the dissolution is the rate-limiting step in the absorption process.
The feasibility of using dense gas techniques such as rapid expansion of supercritical solutions (RESS) and aerosol solvent extraction system (ASES) for micronization of pharmaceutical compounds is demonstrated. The chiral nonsteroidal anti-inflammatory racemic ibuprofen is soluble in carbon dioxide at 35°C and pressures above 90 bar. The particle size decreased to less than 2 μm while the degree of crystallinity was slightly decreased when processed by RESS. The dissolution rate of the ibuprofen (a poorly water-soluble compound) was significantly enhanced after processing by RESS. The nonsteroidal anti-inflammatory drug Cu 2 (indomethacin) 4 L 2 (Cu-Indo); (L = dimethylformamide [DMF]), which possessed very low solubility in supercritical CO 2 , was successfully micronized by ASES at 25°C and 68.9 bar using DMF as the solvent and CO 2 as the antisolvent. The concentration of solute dramatically influenced the precipitate characteristics. The particles obtained from the ASES process were changed from bipyramidal to spherical, with particle size less than 5 μm, as the concentration increased from 5 to 100 mg/g. A further increase in solute concentration to 200 mg/g resulted in large porous spheres, between 20 and 50 μ, when processing Cu-Indo by the ASES method. The dissolution rate of the micronized Cu-Indo was significantly higher than the commercial product.
Dense gas techniques, utilizing the properties of fluids in the vicinity of the critical point, have been used for particle design purposes. 1 Micronization by dense gases is a convenient method because of the relative ease by which the properties can be manipulated by temperature and pressure. A supercritical fluid such as carbon dioxide (with critical temperature of 31.1°C and critical pressure of 72.9 bar) is commonly used as a dense gas. The process, therefore, performs at moderate temperature, which is suitable for many heat labile compounds such as proteins and biocompatible polymers. 1, 2 Micronization and recrystallization of pharmaceutical compounds using dense gases has many advantages over conventional techniques such as spray drying, jet milling, grinding, and liquid antisolvent techniques.
1,2 The advantages include minimum product contamination; reduced waste streams; enabling the processing of thermolabile, shock-and chemically sensitive compounds; and the possibility of producing particles with narrow size distribution in a single-step operation.
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micronization, anti-inflammatory drug, rapid expansion of supercritical solution (RESS), aerosol solvent extraction system (ASES) Supercritical fluids as solvents or antisolvents can be used for the generation of fine powder. 1 The process is called rapid expansion of supercritical solutions (RESS) when the supercritical fluid (SCF) is a solvent and is used when the compound of interest is soluble in the SCF. 1 The technology is known as the gas antisolvent (GAS) process and the aerosol solvent extraction system (ASES) when the SCF is an antisolvent. These techniques are used when the compound has limited solubility in the SCF.
The RESS is a method of particle formation, recrystallization and particle size reduction, and powder mixing. [3] [4] [5] In this process, the solute is first dissolved in a SCF, which is then subjected to rapid expansion by passing it through a nozzle at sonic speeds. During expansion, the density and solvation power of the SCF decreases dramatically, resulting in a high degree of solute supersaturation and subsequent precipitation of solute particles. The combination of high supersaturation ratios and a rapid propagating mechanical perturbation is a distinguishing characteristic of the RESS process.
The major limitation of using RESS in pharmaceutical applications is that some pharmaceutical material including high molecular weight compounds, such as proteins and polymers, are insoluble in supercritical carbon dioxide at moderate conditions (< 60°C and 300 bar). The low solubility necessitates either using large quantities of the SCF or using polar cosolvents, which can complicate the phase behavior of the system and may remain in the precipitated product.
The low solubility of the pharmaceutical compounds in SCFs can be an advantage in dense gas antisolvent techniques. In the gas antisolvent technique, the solute is soluble in the organic solvent, and the solvent is completely or partially miscible with the dense gas. There are 2 modes of performing gas antisolvent recrystallization. 1 The first mode, known as the GAS process, involves the gradual addition of antisolvent to the organic solution containing the solute until precipitation occurs. The second mode, known as the ASES, involves introducing the organic solution of the solute through a capillary nozzle into a flowing dense gas stream. 1 The recent high level of interest in antisolvent techniques stems from the fact that they are more flexible than conventional processes and are broadly applicable.
In the GAS process, rapid crystallization is induced by introducing the gas antisolvent into a solution containing dissolved solute. The dissolution of the dense gas in liquids is often accompanied by large volume expansion, and consequently a reduction in the solvent power of the liquid. Rapid addition of SCF results in a sudden reduction in the density of the liquid, a drastic rise in the supersaturation within the liquid mixture, and the subsequent formation of small and uniform particles.
In the ASES process, which is a continuous process, the solute can be precipitated by spraying the liquid solution into a dense gas. The mechanism of precipitation in the ASES process is more complicated than for the GAS technique. In this process the mass transfer, the hydrodynamics and thermodynamics of the system influence the precipitation. It has been proposed that the precipitation mechanism in an ASES system is a function of operating conditions. 6 At subcritical conditions, the precipitation mechanism is based on the hydrodynamics of the process, atomization and droplet formation. At supercritical conditions the droplets are not formed, and the rapid decrease in surface tension around the jet results in the solvent spreading out in a similar manner to a gaseous jet. Nucleation and growth of particles occurs within this gaseous plume. Both mechanisms are supported by results obtained in the literature and the exact mechanism in operation appears to be system dependent. 1, 6 In this study, an example of the particle formation by both RESS and ASES is presented to demonstrate the broad application of dense gas techniques for particle design purposes. The compounds selected are ibuprofen and copper indomethacin (Cu-Indo). Ibuprofen is a chiral nonsteroidal anti-inflammatory drug that possesses limited solubility in water. It is most often prescribed to treat arthritis, fever, menstrual symptoms, and pain. The required doses of ibuprofen can be minimized by improving its effectiveness in terms of increasing the dissolution rate in the biological environment.
Copper indomethacin is used as a nonsteroidal antiinflammatory drug and can not be orally administered because of the loss of bioavailability in the gastrointestinal tract. A micronized form of the drug may be used for aerosol drug delivery or other administration routes such as suspension for injection.
MATERIALS AND METHODS

Materials
Racemic ibuprofen (99.8% purity) was purchased from Sigma Chemical Co (St. Louis, MO). Potassium phosphate monobasic (99% purity, Sigma), sodium hydroxide (98% purity, Sigma), and sodium lauryl sulfate (SLS) (Sigma) were used to prepare phosphate buffer solution for the dissolution studies. Copper indomethacin (90% purity) was donated by Biochemical Veterinary Research Company (NSW, Australia). N,N-dimethylformamide (DMF) (99.9% purity) was purchased from Honeywell Burdick & Jackson (Muskegon, MI). Carbon dioxide (industrial grade, 99.95% purity) (BOC Gases, Australia) was used as a dense gas fluid. All chemicals and reagents were used without further purifications. 
Procedure
RESS:
The schematic diagram of the RESS apparatus is shown in Figure 1 . In general, the RESS apparatus consists of 2 main units: the extraction or solublization unit and the precipitation unit. In the extraction unit, the extraction vessel is packed with the solute and placed in a constant temperature environment. The SCF is then passed through a preheater and the vessel at a particular temperature and pressure. After equilibrium, the saturated solution is passed through an expansion device, such as a capillary nozzle, which is located in the precipitation unit. The details of the experimental technique have been described previously. 7 ASES: The schematic diagram of the ASES apparatus is presented in Figure 2 . Micronization by the ASES process was conducted by first pressurizing the precipitation vessel to the desired pressure and then allowing the CO 2 to flow through the vessel from the top. The CO 2 flow rate was controlled by a needle valve located at the exit of the chamber. After the system was in steady state, the solution was pumped into the precipitation vessel through the nozzle using the High Performance Liquid Chromatography (HPLC) pump (Waters 500, MA). Once enough precipitate had been collected for analysis, the flow of solution was stopped, and the precipitate was washed with at least 200 mL CO 2 at a desired pressure. The reaction vessel was then depressurized, and samples of precipitate were taken for analysis. A comprehensive description of the procedure was reported previously. 8 
Particle Characterization
Particle morphology of the solid precipitate was determined using a scanning electron microscope (SEM) (Hitachi S4500, Pleasanton, CA). The samples were mounted on metal plates and gold coated using a sputter coater under vacuum. Particle size distributions of the powders were determined using laser diffraction (Mastersizer, Malvern, UK). The experimental techniques for the dissolution rate of the drug have been described in detail in previous papers.
7,8
RESULTS AND DISCUSSION
Micronization of Ibuprofen by RESS Process
The particle size of the original racemic ibuprofen received from Sigma was as high as 250 μm as shown in Figure 3A . Ibuprofen particles precipitated by the RESS process at 35°C and 190 bar were significantly smaller than the original material. The SEM images of processed particles, as illustrated in Figure 3B , reveal that particle size was less than 2 μm. Although the SEM images showed that the particles were aggregated, they were easily dis- persed upon ultrasonification in water as confirmed by the results of particle size distribution measured by Malvern Mastersizer. 7 Process parameters such as temperature, pressure, and nozzle design did not significantly influence the ibuprofen precipitate characteristics. The composition of enantiomer in racemic ibuprofen was 1:1 and did not change while processed by the RESS technique. 7 The x-ray diffraction analysis indicated a negligible reduction in the ibuprofen degree of crystallinity. 7 The dissolution rate of the micronized ibuprofen was found to be 5 times higher than that of the original material as shown in Figure 4 . The enhanced dissolution rate of ibuprofen was attributed to the reduction in the particle size and the increase in surface area.
The effect of adding a surfactant on the dissolution rate of ibuprofen powders was also examined. 7 In this study, 100 mg of sodium lauryl sulfate (SLS) was dissolved in 1.0 L of the dissolution medium. As can be seen from Figure 4 , the dissolution rates of RESS product and original material were both enhanced in the surfactant treated medium. These enhanced dissolution rates indicated more efficient wetting and improved powder dispersion in the presence of surfactant. It was also found that the micronized ibuprofen exhibited a similar dissolution rate to that obtained for the original material combined with surfactant. This result demonstrates that the use of surfactant in the drug formulation can be eliminated when the micronized ibuprofen is used.
Micronization of Cu-Indo by the ASES Process
The effect of Cu-Indo concentration in DMF solution on particle formation in the ASES process performed at 25°C and 68.9 bar was examined. Examples of Cu-Indo particles produced from DMF solutions containing Cu-Indo at various concentrations are shown in Figure 5 . The Cu-Indo particles produced from solutions at a concentration of 5 mg/g ( Figure 5A ) had a bipyramidal morphology and were less than 5 μm in size. Those produced from solutions at a concentration of 20 mg/g ( Figure 5B ) had a predominantly spherical morphology with diameters less than 5 μm. A few particles with a bipyramidal morphology were also evident among the particles with a spherical morphology. The bipyramidal particles were of a similar size to the particles with a spherical morphology. The Cu-Indo particles produced from solutions with a concentration of 100 mg/g ( Figure 5C ) had a spherical morphology with diameters less than 5 μm. At a Cu-Indo concentration of 200 mg/g (Figure 5D ), the particles produced were spherical with diameters ranging from 20 to 50 μm. The surface of the spheres was either smooth or made up of smaller bipyramidal particles. In the case of the ASES processing of Cu-Indo the particle formation appears to be a combination of both mechanisms; crystallization at supercritical conditions and atomisation at subcritical conditions discussed earlier. [8] [9] [10] A negligible change in particle size is observed when increasing Cu-Indo concentration between 5 and 100 mg/g, but an increase in particle size is observed when increasing the Cu-Indo concentration to 200 mg/g. The spherical particles formed at 20 and 100 mg/g concentrations of Cu-Indo appear to be formed from liquid droplets. The formation of spherical particles is not always indicative of droplet formation but may be an indication of a loss of particle crystallinity. Loss of particle crystallinity has been attributed to extremely high levels of supersaturation and rapid nucleation rates preventing the organization of molecules into a crystalline form. [9] [10] It is feasible that spherical particles can result from nucleation and growth within a gaseous plume. The x-ray diffraction analysis confirmed that the generation of spherical particles of Cu-Indo was due to a decrease in the degree of crystallinity after processing by the ASES process. 8 Cu-Indo bipyramidal particles among the larger spheres may be a result of the disintegration of the larger spheres. Reverchon and co-workers have proposed that the presence of such particles was the result of "exploding balloons." 10 The proposed mechanism is based on the formation of a droplet and the subsequent formation of many particles in each droplet. At high enough expansion rates, the droplets continue to expand until they "explode" resulting in many individual particles.
Increasing the concentration of Cu-Indo in DMF from 5 to 200 mg/g results in a dramatic change in particle size and morphology. The ASES particle formation mechanism at 5 mg/g Cu-Indo concentrations is most likely one of nucleation and growth within a gaseous plume. At concentrations between 20 and 100 mg/g, the particle formation mechanism may be either droplet formation or gaseous mixing. At Cu-Indo concentrations of 200 mg/g, the increased viscosity and surface tension of the solution results in delayed jet breakup and particles forming from large droplets.
In terms of micronization, the ASES-produced particles of Cu-Indo were suited to drug delivery applications. The results from the particle size distribution study showed that 90% of the mass of precipitate produced contained particles that were less than 10 μm in diameter. 8 Particle sizes below 10 μm can be used as injectable suspensions and as suspensions for ophthalmic applications. The immediate benefit of micronizing Cu-Indo was demonstrated with an 8-fold increase in dissolution rate in water compared with the unprocessed drug. 8 
CONCLUSION
The results of this study demonstrate that poorly watersoluble ibuprofen and Cu-Indo were successfully micronized by the dense gas techniques. Many factors have to be considered in the selection of the appropriate technique. Ibuprofen with a high level of solubility in CO 2 was processed using RESS, while Cu-Indo with no solubility in CO 2 was processed by the ASES technique. The particle size of the ibuprofen was less than 5 μm and was not substantially changed by variation of operating parameters. The particle size and morphology of Cu-Indo was a function of solution concentration. The dissolution rate of both drugs was substantially improved after processing by the dense gas techniques. The RESS and ASES are efficient for generating micron-sized particles of compounds suitable for special delivery systems. Based on the need for reasonably high drug solubilities in SCFs to make RESS commercially viable, it appears that the antisolvent recrystallization techniques may be more broadly applicable. Supercritical fluid technology provides a processing option for size reduction and recrystallization of pharmaceuticals in a single-step operation at moderate temperature.
